Company Presentation

We are breaking new ground in the treatment of digestive diseases.
Our goal is to develop a series of innovative patient-centered oral enzyme digestive therapies based on our proprietary nanotechnology platform.
Twelve months away from the clinics, we are a fast-growing company engaged in early partnering for the joint development of our rich pipeline.